Nordic Countries
Need information ?
Contact us
You are here
First-Half 2020 Results
02 September, 2020- Organic sales growth of 15.7% in first-half 2020:
- €1,476 million in sales
- Up 15.8% as reported
- As expected, a mixed sales performance, with faster momentum in molecular biology solutions contrasting with a slowdown in microbiology, immunoassays and industrial applications
- Robust growth in contributive operating income before non-recurring items, to €253 million, or 17.1% of sales
Alexandre Mérieux, Chairman and Chief Executive Officer, said: “In today’s unprecedented health crisis, bioMérieux’s positioning as a specialist in infectious disease diagnostics takes on all of its meaning and allowed to rapidly provide high-performance solutions for diagnosing COVID-19. Despite the pandemic’s negative impact on certain product lines and taking into account health and economic conditions, bioMérieux is expected to deliver a remarkable performance this year. However, this performance is not projectable beyond 2020.”
Pioneering Diagnostics
- Clinical Diagnostics
- Industrial Microbiology
- News & Events
- Resources
- About us
- Contact Info
- My selection
bioMérieux Sweden AB - Hantverksvägen 15 - SE-436 33 Askim, SWEDEN
- Legal Notice
- Privacy
- Cookie Policy
- Sitemap
- Contact
- Copyright 2022 bioMérieux SA